Paeoniflorigenone inhibits the progression of cholangiocarcinoma via HIF1A and enhances the chemotherapy sensitivity of cisplatin
Fields of Study & Subjects
Cholangiocarcinoma and Gallbladder Cancer Studies
Hepatocellular Carcinoma Treatment and Prognosis
Cancer
Hypoxia
and Metabolism
Publication details
- Journal / source
- Naunyn-Schmiedeberg s Archives of Pharmacology
- Volume
- 399
- Issue
- 7
- Pages
- 9955–9968
- Publication date
- 28 January 2026
- Language
- EN